Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialEurope PMCOpen access

Safety and Efficacy of Intra-articular Cell-Free Fat Extract Injection in Patients With Symptomatic Knee Osteoarthritis

Xie K., Jia Z., Sun L., Wu J., Jiang X., Wang L.

Randomized Controlled Trial with a reported sample of 24 on Knee Osteoarthritis, Osteoarthritis, published in Orthop J Sports Med (2026) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Orthop J Sports Med (2026)
Reported sample size
24
Source database
Europe PMC
PMID
41970206
PMCID
PMC13065288
DOI
10.1177/23259671261431840

Abstract (original English)

Background Cell-free fat extract (CEFFE) has shown promising therapeutic effects on osteoarthritis (OA) in preclinical studies, but its clinical role remains unclear. Purpose To evaluate the safety and efficacy of intra-articular autologous CEFFE injections for symptomatic early- and mid-stage knee OA. Study design Randomized controlled trial; Level of evidence, 2. Methods A total of 24 participants were randomly allocated to 1 of 4 groups to receive 5 weekly injections of (1) hyaluronic acid (HA, active comparator), (2) low-dose CEFFE (containing 1 mL CEFFE), (3) medium-dose CEFFE (containing 1.5 mL CEFFE), or (4) high-dose CEFFE (containing 2 mL CEFFE). Autologous CEFFE was prepared by spin, emulsification, and filtration after abdominal liposuction, effectively removing lipid and cellular components. Information regarding adverse effects was collected. Routine blood tests, C-reactive protein levels, liver function tests, and kidney function tests were performed at baseline and at the 24-week follow-up to assess systemic toxic effects of CEFFE injection. The clinical effectiveness of CEFFE injections was evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and visual analog scale (VAS) scores. Magnetic resonance imaging (MRI) was used to detect changes in bone marrow lesions (BMLs) and cartilage loss at baseline and at the final follow-up

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research